Company intelligence / Profile preview

iRiva Medical

Minneapolis, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

iRiva Medical is a development-stage company recently funded to commercialize innovative neuromodulation platforms for the treatment of chronic diseases. No clinical or human study results disclosed as of the latest financing round. They recently raised an initial financing round led by F-Prime, Hatteras Venture Partners, Norwest, and Treo Ventures. Steve Masson was appointed as CEO in 2025. Their technology and programs remain in the preclinical or early development stage as of November 2025.

Therapeutic areas: Other
Modalities: DeviceNeuromodulation
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on iRiva Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iRiva Medical.

Explore the full profile